PT73679B - Process for the preparation of pharmaceutical compositions containing as active ingredients a synergistical mixture of oneor more of substituted benzoxadiazole pyridine and/or benzosulphadiazole pyridine with a beta-adrenergic receptor blocking agent and optionally a vasodilator nitrate efficient against coronary diseases and hypertension - Google Patents

Process for the preparation of pharmaceutical compositions containing as active ingredients a synergistical mixture of oneor more of substituted benzoxadiazole pyridine and/or benzosulphadiazole pyridine with a beta-adrenergic receptor blocking agent and optionally a vasodilator nitrate efficient against coronary diseases and hypertension

Info

Publication number
PT73679B
PT73679B PT73679A PT7367981A PT73679B PT 73679 B PT73679 B PT 73679B PT 73679 A PT73679 A PT 73679A PT 7367981 A PT7367981 A PT 7367981A PT 73679 B PT73679 B PT 73679B
Authority
PT
Portugal
Prior art keywords
pyridine
benzosulphadiazole
synergistical
oneor
vasodilator
Prior art date
Application number
PT73679A
Other languages
English (en)
Portuguese (pt)
Other versions
PT73679A (en
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT73679A publication Critical patent/PT73679A/pt
Publication of PT73679B publication Critical patent/PT73679B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT73679A 1980-09-18 1981-09-16 Process for the preparation of pharmaceutical compositions containing as active ingredients a synergistical mixture of oneor more of substituted benzoxadiazole pyridine and/or benzosulphadiazole pyridine with a beta-adrenergic receptor blocking agent and optionally a vasodilator nitrate efficient against coronary diseases and hypertension PT73679B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8030226 1980-09-18

Publications (2)

Publication Number Publication Date
PT73679A PT73679A (en) 1981-10-01
PT73679B true PT73679B (en) 1983-05-11

Family

ID=10516152

Family Applications (1)

Application Number Title Priority Date Filing Date
PT73679A PT73679B (en) 1980-09-18 1981-09-16 Process for the preparation of pharmaceutical compositions containing as active ingredients a synergistical mixture of oneor more of substituted benzoxadiazole pyridine and/or benzosulphadiazole pyridine with a beta-adrenergic receptor blocking agent and optionally a vasodilator nitrate efficient against coronary diseases and hypertension

Country Status (20)

Country Link
US (1) US4510150A (instruction)
JP (1) JPS5782315A (instruction)
AT (1) AT381023B (instruction)
AU (1) AU558670B2 (instruction)
BE (1) BE890311A (instruction)
CA (1) CA1177754A (instruction)
CH (1) CH655658B (instruction)
DE (1) DE3136031A1 (instruction)
FR (1) FR2490092A1 (instruction)
GR (1) GR75349B (instruction)
HU (1) HU190355B (instruction)
IE (1) IE51791B1 (instruction)
IL (1) IL63854A (instruction)
IT (1) IT1171533B (instruction)
NL (1) NL8104246A (instruction)
NZ (1) NZ198368A (instruction)
PH (1) PH19782A (instruction)
PT (1) PT73679B (instruction)
SE (1) SE461014B (instruction)
ZA (1) ZA816515B (instruction)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
JPS5978186A (ja) * 1982-10-27 1984-05-04 Yoshitomi Pharmaceut Ind Ltd １，４−ジヒドロピリジン−３，５−ジカルボン酸エステル誘導体
DE3419131A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Dihydropyridinkombinationspraeparate und verfahren zu ihrer herstellung
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
DE3610037A1 (de) * 1986-03-21 1987-09-24 Schering Ag Nifedipinkombinationspraeparat
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832470A (en) * 1968-01-29 1974-08-27 H Russek Treatment of angina pectoris with a long-acting vasodilating agent and a beta adrenergic receptor blocking agent
ZA742728B (en) * 1973-05-08 1975-04-30 Simes Pharmaceutical composition for the treatment of coronaric ailments
GB1513742A (en) * 1975-01-31 1978-06-07 Ici Ltd 6-aryl-2,3,6,7-tetrahydro-5h-pyrrolo(1,2-a)imidazole derivatives processes for their manufacture and compositions containing them
GB1527543A (en) * 1976-04-15 1978-10-04 Degussa Basically substituted xanthine derivatives
FI64938C (fi) * 1977-06-20 1984-02-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
DK525179A (da) * 1978-12-18 1980-06-19 Sandoz Ag Fremgangsmaade til fremstilling af benzoxadiazoler og benzothiazoler

Also Published As

Publication number Publication date
ATA401181A (de) 1986-01-15
IL63854A0 (en) 1981-12-31
SE8105497L (sv) 1982-03-19
IE812157L (en) 1982-03-18
GR75349B (instruction) 1984-07-13
JPH0160009B2 (instruction) 1989-12-20
CA1177754A (en) 1984-11-13
NZ198368A (en) 1985-08-30
AU7544381A (en) 1982-04-01
AT381023B (de) 1986-08-11
CH655658B (instruction) 1986-05-15
ZA816515B (en) 1983-04-27
IE51791B1 (en) 1987-04-01
SE461014B (sv) 1989-12-18
AU558670B2 (en) 1987-02-05
NL8104246A (nl) 1982-04-16
IT8149305A0 (it) 1981-09-16
FR2490092A1 (fr) 1982-03-19
IL63854A (en) 1985-08-30
JPS5782315A (en) 1982-05-22
PT73679A (en) 1981-10-01
FR2490092B1 (instruction) 1984-11-09
DE3136031C2 (instruction) 1993-02-11
DE3136031A1 (de) 1982-04-08
HU190355B (en) 1986-08-28
BE890311A (fr) 1982-03-11
US4510150A (en) 1985-04-09
PH19782A (en) 1986-07-02
IT1171533B (it) 1987-06-10

Similar Documents

Publication Publication Date Title
PT71724B (en) Process for the preparation of new optically active 1,4-dihidropyridine derivatives having anti-hypertensive and vasodilator effect and of pharmaceutical compositions containing them
PT79615A (en) Process for the preparation of analgesic compositions containing 17-(cyclopropylmethyl)-x-(1,1-dimethyethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinane-7-methanol and 1-n-alyl-14-hydroxynordihydromorphinone
ZA802620B (en) Steroid alkaloids and pharmaceutical compositions containing them
IL60326A0 (en) Pharmaceutical compositions for parenteral administration of fatsolbule active substances
DE3366393D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
PT81007A (en) Process for the preparation of analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives and of pharmaceutical compositions containing the same
PT81102A (en) Process for the preparation of triazol derivatives and of antagonist herbicide compositions containing such derivatives
DE3271990D1 (en) Therapeutically active compound and pharmaceutical composition containing the same
HUT37781A (en) Process for producing 1-fluorphenyl-butyl-4-/2-pirimidinyl/-piperazine derivatives and pharmaceutical compositions containing them as active agents
DE3267673D1 (en) Phospholipid derivatives, processes for preparation thereof and pharmaceutical composition of the same
DE3062586D1 (en) 2-imidazoline derivatives, process for the preparation thereof and the pharmaceutical composition of the same
HUT38897A (en) Process for producing pharmaceutically active substituted benzamides and pharmaceutical compositions containing them as active agents
EP0147211A3 (en) 4h-3,1-benzoxazin-4-ones and related compounds, pharmaceutical compositions containing them, and processes for their preparation
ZA777532B (en) 1,4-dihydropyridine compounds,process for preparation thereof and pharmaceutical composition of the same
HUT34024A (en) Process for preparing ergoline derivatives and pharmaceut compositions containing thereof as active substances
PT73679B (en) Process for the preparation of pharmaceutical compositions containing as active ingredients a synergistical mixture of oneor more of substituted benzoxadiazole pyridine and/or benzosulphadiazole pyridine with a beta-adrenergic receptor blocking agent and optionally a vasodilator nitrate efficient against coronary diseases and hypertension
JPS55111494A (en) Monophosphonate compound* its manufacture and therapeutic composition containing same as active ingredient
AU4150285A (en) Stable pharmaceutical compositions of short-accting beta- adrenergic receptor blocking agents
HUT39437A (en) Process for producing new morpholinol derivatives and pharmaceutical compositions containing them as active agents
PT71066A (en) Process for the preparation of a pharmaceutical composition having analgesic and myotonolytical activity
HUT39450A (en) Process for producing imidazobicyclic compounds and pharmaceutical compositions containing them as active agents
PT76870A (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
IL61175A0 (en) 1,2,4-oxadiazolin-5-one derivatives,process for their preparation and pharmaceutical compositions containing them
PT76734A (en) Process for preparing therapeutically active dihydropyridines of intermediates for the process and of pharmaceutical compositions containing the same
HUT40556A (en) Insecticide composition containing oxim-ether derivatives as active agents and process for producing the active agents

Legal Events

Date Code Title Description
PC3A Transfer or assignment

Free format text: 971017 NOVARTIS AG CH

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19981130